ALZECURE PHARMA ABALZECURE PHARMA ABALZECURE PHARMA AB

ALZECURE PHARMA AB

No trades
See on Supercharts

ALZCUR fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

AlzeCure Pharma AB is a pharmaceutical research company. It engages in the development of drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The firm is developing parallel drug candidates based on the research platforms, such as NeuroRestore, Alzstatin, and Painless. The company was founded by Johan Sandin, Gunnar Nordvall, Pontus Forsell, Johan Lundkvist, and Magnus Halldin on November 22, 2016 and is headquartered in Huddinge, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ALZCUR does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company